PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.

Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA. · 2015

Read PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. by Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4389235.txt.

Introduction

Nikolaos Patsoukis and co-authors showed how the immune brake PD-1 rewires T-cell fuel use, in Nature Communications in 2015. When T cells switch on, they normally shift their metabolism toward sugar burning to power rapid growth and attack. PD-1 is a receptor that restrains T cells, and blocking it revives anti-tumor responses. The team asked what PD-1 engagement does to the fuel choices of activated T cells, and how that shapes their fate.

Cells receiving PD-1 signals could not engage sugar burning or amino-acid use. Instead they burned their own fats faster, raising a fat-transport protein and a fat-splitting enzyme, with glycerol and fatty acids released as signs. A second brake, CTLA-4, blocked sugar burning without raising fat burning. Forced sugar dependence during effector growth explains why PD-1 stalls that growth, and fat burning may explain the long life of PD-1-signaled cells.

Catalog record

CREATORPatsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4389235

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation By Nikolaos Patsoukis, Kankana Bardhan, Pranam Chatterjee, Duygu Sari, Bianling Liu, Lauren N. Bell, Edward D. Karoly, Gordon J. Freeman, Victoria Petkova, Pankaj Seth, Lequn Li, Vassiliki A. Boussiotis Published in: Nature Communications DOI: 10.1038/ncomms7692 ABSTRACT During activation, T cells undergo metabolic reprogramming, which imprints distinct functional fates. We determined that on PD-1 ligation, activated T cells are unable to engage in glycolysis or amino acid metabolism but have an increased rate of fatty acid β-oxidation (FAO). PD-1 promotes FAO of endogenous lipids by increasing expression of CPT1A, and inducing lipolysis as indicated by elevation of the lipase ATGL, the lipolysis marker glycerol and release of fatty acids. Conversely, CTLA-4 inhibits glycolysis without augmenting FAO, suggesting that CTLA-4 sustains the metabolic profile of non-activated cells. Because T cells utilize glycolysis during differentiation to effectors, our findings reveal a metabolic mechanism responsible for PD-1-mediated blockade of T-effector cell differentiation. The enhancement of FAO provides a mechanistic explanation for the longevity of T cells receiving PD-1 signals in patients with chronic infections and cancer, and for their capacity to be reinvigorated by PD-1 blockade. Maintenance of peripheral tolerance is essential for homeostasis of the immune system. While central tolerance mechanisms result in deletion of the majority of self-reactive T cells, some T lymphocytes specific for self-antigens escape this process and circulate in the periphery. PD-1 (CD279) and its ligands, PD-L1 (B7-H1; CD274) and PD-L2 (B7-DC; CD273), play a vital role in peripheral tolerance1. PD-1 exerts its effects during the initial phase of activation of autoreactive T cells on self-antigen presentation by DC. In addition, PD-L1/2, expressed on non-haematopoietic tissues, mediate tissue tolerance by suppressing tissue-reactive T cells23. In contrast to its beneficial role in maintaining self-tolerance, PD-L1/2 expressed on malignant tumours or tumour-infiltrating myeloid cells, mediate potent inhibitory signals on effector T cells and have detrimental effects on anti-tumour immunity45. Moreover, expression of PD-1 by ‘exhausted’ T cells in chronic viral infections prevents the function of virus-specific T-cell effectors and viral clearance67. Naïve T cells utilize oxidative phosphorylation (OXPHOS) for energy generation. On activation via the T cell receptor, T cells undergo a metabolic reprogramming to glycolysis, which is required to support their growth, effector differentiation and function89. Although energetically less efficient, glycolysis is required for cell growth. Conventional views suggest that proliferating cells have a high rate of aerobic glycolysis, even though there is sufficient oxygen present to support OXPHOS, a phenomenon known as the Warburg effect10. Signals from the CD28 co-stimulatory pathway and the γ-chain signalling cytokines support activation, growth and expansion of T cells by promoting this metabolic programme1112. Divergence in the metabolic reprogramming is critical to effectively imprint distinct T-cell fates. This has been shown with the switch to glycolysis that accompanies effector T-cell differentiation13 and the switch to fatty acid β-oxidation (FAO) that accompanies the conversion of T-effector to T-memory cells 14. Furthermore, enforcing FAO by elevating AMPK activity or by inhibiting the mammalian target of rapamycin resulted in increased numbers of memory T cells1415. It remains unknown whether the functional outcome of PD-1 ligation is linked to T-cell reprogramming to a specific metabolic pathway. We investigated the metabolism of T cells receiving PD-1 signals and discovered that they were unable to engage in glycolysis, glutaminolysis or metabolism of branched-chain amino acids but displayed an increased rate of FAO. PD-1 promoted FAO of endogenous lipids by increasing the rate-limiting enzyme of FAO, carnitine palmitoyl transferase (CPT1A) and inducing lipolysis as determined by the increase of the major triacylglycerol (TG) hydrolase desnutrin/adiposite triglyceride lipase (ATGL) and release of fatty acids and glycerol. In addition to increased FAO, T cells stimulated in the presence of PD-1 ligation possessed substantial spare respiratory capacity (SRC), the extra mitochondrial capacity available in the cell to produce energy under conditions of stress. Because burning fat has a strong association with longevity in many cell types161718, these unexpected findings indicate that PD-1 ligation enables T cells to survive as long-lived cells by utilizing a fat-based metabolism. In contrast, CTLA-4 inhibited expression of the glutamine transporters SNAT1 and SNAT2, and the glucose transporter Glut1 and inhibited glycolysis without augmenting CPT1A and FAO, suggesting that CTLA-4 maintains immune quiescence by preserving the metabolic profile of non-stimulated cells. PD-1 also altered the metabolic programme of pre-activated CD4+ T cells and reprogrammed their metabolism from glycolysis to FAO. Because PD-1 is expressed on activated T cells, which employ glycolysis as the dominant source of energy generation during differentiation into effectors, our findings indicate that PD-1 ligation prevents effector cell development by altering metabolic reprogramming of activated T cells by inhibiting glycolysis and promoting FAO. Furthermore, the enhancement of FAO suggests a mechanism responsible for the survival and persistence of T cells receiving PD-1 signals in patients with chronic infections and cancer and for their capacity to be reinvigorated by PD-1 blockade. RESULTS PD-1 abrogates transport and utilization of glucose Activation of naïve CD4+ T cells is accompanied by effector differentiation, which depends on aerobic glycolysis13. To examine the effects of PD-1 on this physiologic mechanism of energy generation on T-cell stimulation, we employed a previously established experimental system19 of highly purified human CD4+ T cells that were stimulated with magnetic beads conjugated with anti-CD3, anti-CD28 monclonal antibodys (mAbs) and control immunoglobulin-G (IgG; T cells co-stimulated (TCC)) or magnetic beads conjugated with anti-CD3, anti-CD28 mAbs and PD-L1-Ig fusion protein (T cells co-stimulated+PD-1 (TCC+PD1)), similar to an approach previously used in a mouse cell system20. This approach has been designed to mimic the physiologic conditions of primary T-cell activation by antigen-presenting cells (APCs), which leads to engagement of PD-1 and TCR/CD3 complex. Culture of T cells with simultaneous ligation of PD-1 inhibited production of IFN-γ (Fig. 1a), consistent with the known effect of PD-1 signalling on T-cell effector responses. To uptake glucose from the microenvironment, T cells must upregulate the glucose transporter Glut1 (ref. 8). We determined that Glut1 expression was upregulated in TCC, but Glut1 upregulation was less prominent in TCC+PD1 cells (Fig. 1b). As a consequence, TCC but not TCC+PD1 cells displayed robust glucose uptake (Fig. 1c). Metabolite analysis in TCC cells showed increased glucose utilization for glycolysis, as determined by reduction of intracellular glucose and the pentose phosphate pathway precursor 6-phosphogluconate and increase of the glycolysis intermediate fructose 1,6-bisohosphate. This was accompanied by depletion of glucose and significant elevation in the metabolic products of glycolysis, pyruvate and lactate, in the corresponding culture supernatants (Fig. 1d, Supplementary Fig. 1 and Supplementary Data 1 and 2). PD-1 largely blocked glucose uptake and glycolysis as evidenced by unchanged levels of glucose and diminished products of glycolysis in TCC+PD1 cultures (Fig. 1d). This effect of PD-1 was not only due to inhibition of Glut 1 expression and glucose transport but also due to inhibition of hexokinase 2 (HK2) (Fig. 1e), which catalyses the first step of glycolysis by converting glucose to glucose-6-phosphate. PD-1 inhibits amino acid transport and metabolism T-cell activation induces changes in amino acid metabolism2122. Amino acids serve as building blocks for protein synthesis, but also contribute to many processes critical for dividing cells including nucleotide synthesis, redox control and energy generation. We examined

Read the complete text